Innovation: Shaping the Future of Pharma (TM)
Innovationand technologies including AI, machine learning, and data analytics, are transforming the future of pharma and biopharmaceutical development and manufacturing.
Good Manufacturing Practices (GMP) and Good Engineering Practices (GEP) are essential for maintaining high-quality production standards. Future pharma and biopharma facilities will be smart and automated, utilizing IoT, robotics, and continuous manufacturing to enhance scalability and efficiency. Effective maintenance will be crucial to ensure reliable, compliant operations.
Advanced Therapy Medicinal Products (ATMPs), such as gene and cell therapies, are revolutionizing treatment options but require robust Chemistry, Manufacturing, and Controls (CMC) to ensure safety and efficacy.
Call for Proposals Timeline
- 1 December 2024: Call for Papers Open
- 28 February 2025: Submission Deadline
- 1 April 2025: Accepted Submissions Notified
Requested Submission Topics
The 2025 Singapore Annual Conference Programme Committee welcomes proposals aligning with the following content areas:
- Digital Transformation and Innovation
- GAMP 5
- Facilities of the Future
- Aseptic Manufacturing & Annex 1
- ATMPs & Biologics Manufacturing
- CDMOs
- Good Engineering Practices & Maintenance
Proposal Submission Types
Presentation
- 20-minute presentation, to be considered as part of a track by the Programme Committee. Where possible, to reference / incorporate the theme, innovations case study examples and application of latest best practices.
- A 5-minute Q&A session follows the presentation.
Panel Discussion
- 45-minute Panel Discussions enable the Moderator and panellists to focus in-depth on emerging trends, with audience participation via polls, questions and comments.
Workshop
- Held concurrently with the main conference, 30-45 minute ‘deep-dive’ sessions allow for key topics to be presented in detail. Formats may include interactive polls, case studies, practical exercises, demonstrations, videos etc to support presentations and discussions.